ABT vs CGBD · P/E 25, rev $44.33B vs P/E 15, $745.0M cap
Abbott Laboratories (ABT) versus Carlyle Secured Lending Inc (CGBD) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Carlyle Secured Lending Inc (CGBD) is a asset management company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
CGBD does not have a complete income-statement cache yet.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CGBD currently screens at market cap $745.0M and trailing P/E 15.3.
Not investment advice. Open the ABT and CGBD stock pages for the full models.
Not investment advice.